Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Validated Method for the Screening of 320 Forensically Significant Compounds in Blood by LC/QTOF, with Simultaneous Quantification of Selected Compounds
Emma Partridge, Stephen Trobbiani, Peter Stockham, et al.
Journal of Analytical Toxicology (2017) Vol. 42, Iss. 4, pp. 220-231
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Clinical toxicity of nitazene detections in two Australian emergency department toxicosurveillance systems
Katherine Isoardi, Sam Alfred, Courtney Weber, et al.
Drug and Alcohol Review (2025)
Open Access | Times Cited: 6
HighResNPS.com: An Online Crowd-Sourced HR-MS Database for Suspect and Non-targeted Screening of New Psychoactive Substances
Marie Mardal, Mette Findal Andreasen, Christian Brinch Mollerup, et al.
Journal of Analytical Toxicology (2019) Vol. 43, Iss. 7, pp. 520-527
Open Access | Times Cited: 83
Data acquisition methods for non-targeted screening in environmental analysis
Yujue Yang, Lili Yang, Minghui Zheng, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 160, pp. 116966-116966
Closed Access | Times Cited: 38
Determination of 21 synthetic cathinones, phenethylamines, amphetamines and opioids in influent wastewater using liquid chromatography coupled to tandem mass spectrometry
Richard Bade, Ahmed M. Abdelaziz, Lynn Nguyen, et al.
Talanta (2019) Vol. 208, pp. 120479-120479
Closed Access | Times Cited: 67
LC-HRMS suspect screening to show spatial patterns of New Psychoactive Substances use in Australia
Richard Bade, Benjamin J. Tscharke, Jason M. White, et al.
The Science of The Total Environment (2018) Vol. 650, pp. 2181-2187
Closed Access | Times Cited: 62
MASS SPECTROMETRY ANALYSIS OF DRUGS OF ABUSE: CHALLENGES AND EMERGING STRATEGIES
Scott A. Borden, Jan Palaty, Veronica Termopoli, et al.
Mass Spectrometry Reviews (2020) Vol. 39, Iss. 5-6, pp. 703-744
Closed Access | Times Cited: 62
International snapshot of new psychoactive substance use: Case study of eight countries over the 2019/2020 new year period
Richard Bade, Jason M. White, Jingjing Chen, et al.
Water Research (2021) Vol. 193, pp. 116891-116891
Open Access | Times Cited: 43
Identification of new psychoactive substances and their metabolites using non-targeted detection with high-resolution mass spectrometry through diagnosing fragment ions/neutral loss analysis
José Manuel Matey, Félix Zapata, Luis Manuel Menéndez-Quintanal, et al.
Talanta (2023) Vol. 265, pp. 124816-124816
Closed Access | Times Cited: 20
A Case Study Involving U-47700, Diclazepam and Flubromazepam—Application of Retrospective Analysis of HRMS Data
Emma Partridge, Stephen Trobbiani, Peter Stockham, et al.
Journal of Analytical Toxicology (2018) Vol. 42, Iss. 9, pp. 655-660
Open Access | Times Cited: 53
U-47700 and Its Analogs: Non-Fentanyl Synthetic Opioids Impacting the Recreational Drug Market
Michael H. Baumann, Graziella Tocco, Donna M Papsun, et al.
Brain Sciences (2020) Vol. 10, Iss. 11, pp. 895-895
Open Access | Times Cited: 43
New Advances in Toxicological Forensic Analysis Using Mass Spectrometry Techniques
Noroska G.S. Mogollón, Cristian Quiroz-Moreno, Paloma Santana Prata, et al.
Journal of Analytical Methods in Chemistry (2018) Vol. 2018, pp. 1-17
Open Access | Times Cited: 46
Monitoring new psychoactive substances use through wastewater analysis: current situation, challenges and limitations
Lubertus Bijlsma, Alberto Celma, Francisco J. López, et al.
Current Opinion in Environmental Science & Health (2019) Vol. 9, pp. 1-12
Open Access | Times Cited: 42
Hyphenated high-resolution mass spectrometry—the “all-in-one” device in analytical toxicology?
Hans H. Maurer
Analytical and Bioanalytical Chemistry (2020) Vol. 413, Iss. 9, pp. 2303-2309
Open Access | Times Cited: 37
Perspectives and challenges associated with the determination of new psychoactive substances in urine and wastewater – A tutorial
Lubertus Bijlsma, Richard Bade, Frederic Béen, et al.
Analytica Chimica Acta (2020) Vol. 1145, pp. 132-147
Closed Access | Times Cited: 36
A simultaneous exploratory and quantitative amino acid and biogenic amine metabolic profiling platform for rapid disease phenotyping via UPLC-QToF-MS
Nicola Gray, Nathan G. Lawler, Rongchang Yang, et al.
Talanta (2020) Vol. 223, pp. 121872-121872
Open Access | Times Cited: 33
Forensic drug screening by liquid chromatography hyphenated with high-resolution mass spectrometry (LC-HRMS)
Pia Johansson Heinsvig, Carolina Noble, Petur Weihe Dalsgaard, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 162, pp. 117023-117023
Open Access | Times Cited: 13
Overview of systematic toxicological analysis strategies and their coverage of substances in forensic toxicology
Karen Rygaard, Meiru Pan, Marie Katrine Klose Nielsen, et al.
Analytical Science Advances (2023) Vol. 4, Iss. 3-4, pp. 96-103
Open Access | Times Cited: 12
Investigating the appearance of new psychoactive substances in South Australia using wastewater and forensic data
Richard Bade, Peter Stockham, Ben Painter, et al.
Drug Testing and Analysis (2018) Vol. 11, Iss. 2, pp. 250-256
Open Access | Times Cited: 36
Direct coupling of MEPS to ESI-QqTOF-MS for the simultaneous analysis of tricyclic antidepressants and benzodiazepines in postmortem blood
Carmina Vejar-Vivar, Luís Bustamante, Rafael Lucena, et al.
Microchemical Journal (2021) Vol. 171, pp. 106797-106797
Closed Access | Times Cited: 24
Liquid Chromatography High-Resolution Mass Spectrometry in Forensic Toxicology: What are the Specifics of Method Development, Validation and Quality Assurance for Comprehensive Screening Approaches?
Sarah M.R. Wille, Brigitte Desharnais, Simona Pichini, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 15, pp. 1230-1244
Closed Access | Times Cited: 18
Screening of new psychoactive substances in human plasma by magnetic solid phase extraction and LC-QTOF-MS
Jinwoo Hwang, Miri Han, Sora An, et al.
Forensic Science International (2022) Vol. 332, pp. 111176-111176
Closed Access | Times Cited: 15
Screening for Forensically Relevant Drugs Using Data-Independent High-Resolution Mass Spectrometry
Maia N. Bates, Abby E. Helm, Heather M. Barkholtz
Chemical Research in Toxicology (2024) Vol. 37, Iss. 4, pp. 571-579
Open Access | Times Cited: 3
A critical review of workplace drug testing methods for old and new psychoactive substances: Gaps, advances, and perspectives
Ahmed I. Al‐Asmari
Saudi Pharmaceutical Journal (2024) Vol. 32, Iss. 5, pp. 102065-102065
Open Access | Times Cited: 3
A Fatality Involving Furanylfentanyl and MMMP, with Presumptive Identification of Three MMMP Metabolites in Urine
Christine Nash, Danielle M. Butzbach, Peter Stockham, et al.
Journal of Analytical Toxicology (2018) Vol. 43, Iss. 4, pp. 291-298
Closed Access | Times Cited: 25
How to perform spectrum-based LC-HR-MS screening for more than 1,000 NPS with HighResNPS consensus fragment ions
Anders Davidsen, Marie Mardal, Kristían Línnet, et al.
PLoS ONE (2020) Vol. 15, Iss. 11, pp. e0242224-e0242224
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top